Surgical Procedures Are Increasingly Imperiled by New Pharmaceuticals

Minnesota's Novel 340B Financial Reporting Program Reveals Revenue Concentration Among Disproportionate Share Hospitals and Specialty Medications

Winning in an Outpatient World: Preparing for Potential Changes to Medicare’s IPO List

Antibiotic Overprescribing Remains High in Certain Provider Types, Care Settings and Regions

Medicare Advantage Utilization Remained Relatively Flat from 2022 to 2023, While Utilization by Care Setting Was Variable

Despite Regulatory Scrutiny, Increases in Adult ADHD Diagnosis and Off-Label Stimulant Prescribing Continued Through 2023

Changes in Coding Intensity Across Outpatient Settings